NephroGenex, Inc. (NRX) [Rocket]

In millions, except per share items	Dec-31-15	Sep-30-15	Jun-30-15	Mar-31-15	Dec-31-14	Sep-30-14	Jun-30-14	Mar-31-14
	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Revenue growth								-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin
Selling, general and administrative [+]	1.7	1.6	2.0	1.7	1.4	1.4	1.6	1.0
General and administrative	1.7	1.6	2.0	1.7	1.4	1.4	1.6	1.0
Research and development	4.1	3.6	4.2	3.4	3.9	3.1	3.9	0.5
EBITDA [+]	-5.8	-5.2	-6.2	-5.0	-5.2	-4.4		-1.5
EBITDA growth	11.4%	17.6%	14.8%	237.8%	398.7%	552.8%	1348.8%	273.2%
EBITDA margin
Depreciation and amortization	0.0	0.0	0.0	0.0	0.0	0.0		0.0
EBIT [+]	-5.8	-5.2	-6.2	-5.0	-5.2	-4.4	-5.4	-1.5
EBIT growth	11.4%	17.7%	14.8%	237.7%	398.9%	552.0%	1349.3%	270.5%
EBIT margin
Interest expense, net [+]	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1
Interest expense	0.1	0.1	0.1	0.1	0.1			0.1
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other income (expense), net [+]								-0.1
Change in fair value of warrants								-0.1
Pre-tax income	-6.0	-5.3	-6.4	-5.2	-5.3	-4.4	-5.4	-1.7
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-6.0	-5.3	-6.4	-5.2	-5.3	-4.4	-5.4	-1.7
Net margin

Basic EPS [+]	($0.60)	($0.53)	($0.72)	($0.58)	($0.67)	($0.50)	($0.61)	($0.37)
Growth	-11.7%	5.5%	17.5%	57.5%	-94.8%	-81.8%	-75.6%
Diluted EPS [+]	($0.60)	($0.53)	($0.72)	($0.58)	($0.67)	($0.50)	($0.61)	($0.37)
Growth	-11.7%	5.5%	17.5%	57.5%	-94.8%	-81.8%	-75.6%

Shares outstanding (basic) [+]	10.0	10.2	8.9	8.9	7.8	8.9	8.9	4.6
Growth	27.8%	14.8%	0.1%	93.2%	2347.0%	2668.2%	2668.2%
Shares outstanding (diluted) [+]	10.0	10.2	8.9	8.9	7.8	8.9	8.9	4.6
Growth	27.8%	14.8%	0.1%	93.2%	2347.0%	2668.2%	2668.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.